The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The new facility will provide an important boost to vaccine capacity in Africa
It is the world’s first DNA-based Covid vaccine
Subscribe To Our Newsletter & Stay Updated
